Preventive Medicine Foundation Quality Assurance Program Center ( PMF QAP Center ) has been providing “EQA Program for Neonatal Glucose-6-Phosphate Dehydrogenase ( G6PD ) Screening Test”using dried blood spot samples collected on filter paper for newborn screening centers since 1999. More than 50 laboratories ( including 6 reagent manufacturer QA laboratories ) worldwide ( AT, AU, CH, CN, DE, FI, GR, IN, LB, MX, PH, TH, TR, TW, US, and VN etc. ) have participated in the EQA program at present time.
The 10th International Society for Neonatal Screening (ISNS) International Symposium was held in Hangzhou (China) on September 19 ~ 22, 2019. We are glad to have the opportunity to meet and communicate with participants of G6PD EQA program.
We invited EQA participants who also attended the 10th ISNS international conference to meet us, and held two EQA participants workshops during the conference. One was held in English on Sep. 19, the other one was held in Chinese on Sep. 20.
第十屆國際新生兒篩檢大會 ( 10th ISNS International Meeting ) 於2019 年 9 月 19 ~ 22 日假中國杭州市舉辦，該國際會議每三年召開一次，為國際上最重要的新生兒篩檢國際研討會議。本會執行長率執行秘書及兩位專案經理一同出席該會議，並於會中發表新生兒篩檢內部品管計畫成效「Internal Quality Control for Newborn Screening by Tandem Mass Spectrometry」論文。
本會協助國民健康署於義大利波隆那舉辦的2018 第 26 屆健康促進醫院國際研討會 ( 26th International Conference on Health Promoting Hospitals and Health Services ) 中共同發表「Outcome of Newborn Glucose-6-Phosphate Dehydrogenase (G6PD) Screening Program in Taiwan」論文。